My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.64 -0.10 (-0.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
AngioDynamics Eyes Growth Despite Tariffs
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected. 
Via Benzinga
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500... 
Via Benzinga
Topics Stocks
Why Did AngioDynamics Stock Pop Today?
Even 37 years after its founding, AngioDynamics still can't earn a profit. 
Via The Motley Fool
What's Fueling The Momentum In AngioDynamics Stock?
Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter. 
Via Benzinga
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results
 
Via Benzinga
Earnings Scheduled For October 2, 2025
 
Via Benzinga
What's Next: AngioDynamics's Earnings Preview
 
Via Benzinga
AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook
AngioDynamics (ANGO) beat Q1 FY2026 earnings and revenue estimates, driven by strong Med Tech growth. The company also raised its full-year financial outlook. 
Via Chartmill
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone
CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level. 
Via Benzinga
Topics Stocks
AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday
US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics. 
Via Benzinga
Earnings Outlook For AngioDynamics
 
Via Benzinga
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings
 
Via Benzinga
Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock
 
Via Benzinga
A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know
 
Via Benzinga
Why AngioDynamics Stock Popped, Then Dropped Today
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed. 
Via The Motley Fool
Topics Earnings
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting
AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says. 
Via Benzinga
Topics World Trade
AngioDynamics (ANGO) Q4 2025 Earnings Transcript
Via The Motley Fool
Topics World Trade
Earnings Scheduled For July 15, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Get insights into the top gainers and losers of Monday's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Gold Moves Higher; US Private Sector Job Growth Tops Estimates
 
Via Benzinga
Traders are paying attention to the gapping stocks in Wednesday's session.
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance
AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth. 
Via Benzinga
These stocks are moving in today's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets
The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical... 
Via Stocktwits
Earnings Scheduled For April 2, 2025
 
Via Benzinga
Uncovering Potential: AngioDynamics's Earnings Preview
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.